Green Thumb Industries: The Stock Is Priced Too Low For What It's Delivering, Jump In
Green Thumb's quarterly revenue grew 4.6% during the quarter, while comps declined 1.1%, reflecting weak retail health of its existing stores. While the company's revenue grew consistently over the past 5 years, its EBITDA margin remained under pressure over the same period due to stiff competition. Overall, I give Green Thumb a buy rating. Low debt level, aggressive share buybacks, and Schedule III reclassification are strong reasons to commit your capital.
Should You Buy, Hold or Sell GTBIF Stock Post Q2 Earnings Release?
On Tuesday, Green Thumb Industries GTBIF reported impressive second-quarter 2026 results, with earnings and sales beating consensus estimates.
Green Thumb Industries Inc. (GTBIF) Q2 2026 Earnings Call Transcript
Green Thumb Industries Inc. (GTBIF) Q2 2026 Earnings Call Transcript
3 Reasons to Buy Green Thumb Industries Stock Hand Over Fist
Green Thumb consistently outperforms many cannabis industry peers. Financial discipline makes this cannabis stock stand out.
GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?
Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist.
Green Thumb Industries Inc. (GTBIF) Q1 2026 Earnings Call Transcript
Green Thumb Industries Inc. (GTBIF) Q1 2026 Earnings Call Transcript
Green Thumb Industries Inc. (GTBIF) Moves 10.0% Higher: Will This Strength Last?
Green Thumb Industries Inc. (GTBIF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Is Green Thumb Stock Oversold? The Case for 100% Upside.
A recent licensing change could pave the way for higher profits.
3 Top Marijuana Stocks For Long-Term Investing 2026
At this time, the cannabis industry is growing at a fast pace. More companies are building and collaborating with other players in the industry to enhance their operations further. In the United States, cannabis regulations and operational guidelines in legal markets are still being updated and improved. Even though the development of a better industry has left the public sector with high levels of volatility.
Green Thumb Industries: Positioned To Consolidate (Rating Upgrade)
Green Thumb Industries Inc. is upgraded to Buy, reflecting disciplined capital allocation, strong free cash flow, and a robust balance sheet amid industry distress. GTBIF's 2025 results show resilient FCF of $214M, manageable $245M debt, and opportunistic share buybacks, positioning it to consolidate as weaker peers falter. Management guides Q1 2026 revenue down mid-single digits due to pricing pressure and seasonality but maintains flexibility for organic growth, acquisitions, and buybacks.
Should You Buy GTBIF Stock After Marijuana Reclassification Order?
Shares of Green Thumb GTBIF jump nearly 35% on a marijuana rescheduling order, but pricing pressure and weak comps cloud the stock's near-term outlook.
Green Thumb: Trump EO To The Rescue
Green Thumb Industries stands to benefit significantly from cannabis rescheduling and the removal of 280E tax burdens. GTBIF trades at ~7x adjusted EBITDA, with potential for a 10x multiple if rescheduling and uplisting materialize. The company maintains strong cash flow, $226 million in cash, and has repurchased $107 million in shares despite tax headwinds.
